Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnaby Nelson

Showing results (191-200 of 311) with videos related to

Pageof 32
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Transdiagnostic clinical staging in youth mental health: a first international consensus statementJai L Shah, Jan Scott, Patrick D McGorry, et al.
Current Pharmaceutical Design|January 14, 2012
Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS studyGregor E Berger, Stephen J Wood, Margaret Ross, et al.
Biological Psychiatry Global Open Science|July 23, 2025
White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for PsychosisLauren F Barker, Allan F McRae, Hok Pan Yuen, et al.
JAMA Psychiatry|April 3, 2024
A Dynamical Systems View of Psychiatric Disorders-Theory: A ReviewMarten Scheffer, Claudi L Bockting, Denny Borsboom, et al.
The Australian and New Zealand Journal of Psychiatry|July 4, 2017
Ventricular volumes across stages of schizophrenia and other psychosesGregor E Berger, Cali F Bartholomeusz, Stephen J Wood, et al.
JAMA Psychiatry|June 7, 2013
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 studyBarnaby Nelson, Hok Pan Yuen, Stephen J Wood, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI StudySidhant Chopra, Alex Fornito, Shona M Francey, et al.
Journal of Affective Disorders|March 16, 2025
Activation differentiates illness trajectories among youth seeking mental health careEmiliana Tonini, Jacob J Crouse, Mirim Shin, et al.
JMIR Mental Health|November 22, 2021
Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling StudyIsabell Paetzold, Karlijn S F M Hermans, Anita Schick, et al.
Early Intervention in Psychiatry|June 20, 2020
Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis populationAndrea Polari, Hok Pan Yuen, Paul Amminger, et al.
Pageof 32

Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Transdiagnostic clinical staging in youth mental health: a first international consensus statementJai L Shah, Jan Scott, Patrick D McGorry, et al.
Current Pharmaceutical Design|January 14, 2012
Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS studyGregor E Berger, Stephen J Wood, Margaret Ross, et al.
Biological Psychiatry Global Open Science|July 23, 2025
White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for PsychosisLauren F Barker, Allan F McRae, Hok Pan Yuen, et al.
JAMA Psychiatry|April 3, 2024
A Dynamical Systems View of Psychiatric Disorders-Theory: A ReviewMarten Scheffer, Claudi L Bockting, Denny Borsboom, et al.
The Australian and New Zealand Journal of Psychiatry|July 4, 2017
Ventricular volumes across stages of schizophrenia and other psychosesGregor E Berger, Cali F Bartholomeusz, Stephen J Wood, et al.
JAMA Psychiatry|June 7, 2013
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 studyBarnaby Nelson, Hok Pan Yuen, Stephen J Wood, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI StudySidhant Chopra, Alex Fornito, Shona M Francey, et al.
Journal of Affective Disorders|March 16, 2025
Activation differentiates illness trajectories among youth seeking mental health careEmiliana Tonini, Jacob J Crouse, Mirim Shin, et al.
JMIR Mental Health|November 22, 2021
Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling StudyIsabell Paetzold, Karlijn S F M Hermans, Anita Schick, et al.
Early Intervention in Psychiatry|June 20, 2020
Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis populationAndrea Polari, Hok Pan Yuen, Paul Amminger, et al.
Pageof 32